Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: A 1-year primate study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 5, 1996, Pages 1933-1939

  Grow, Daniel R ^a,b   Williams, Robert F ^b   Hsiu, J G ^c   Hodgen, Gary D ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c Bon Secours DePaul Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ANTIGESTAGEN; ESTROGEN; GONADORELIN AGONIST; HYDROCORTISONE; LEUPRORELIN; MIFEPRISTONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIOSIS; FEMALE; FLUSHING; HISTOPATHOLOGY; HORMONAL REGULATION; HORMONAL THERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; VERTIGO;

ANIMALS; BONE DENSITY; ENDOMETRIOSIS; ENDOMETRIUM; ESTRADIOL; FEMALE; HORMONE ANTAGONISTS; LEUPROLIDE; MACACA FASCICULARIS; MIFEPRISTONE; PROGESTINS; TIME FACTORS; VAGINA;

EID: 0029940788     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.5.1933     Document Type: Article

References (50)

1. Henzl MR, Corson SC, Moghissi K, Buttram VC, Berqvist C, Jacobson J. 1988 Administration of nasal nafarelin as compared with oral danazol for endometriosis. N Engl J Med. 318:485-489.
2. Barbieri RL, Ryan KJ. 1981 Danazol: endocrine pharmacology and therapeutic applications. Am J Obstet Gynecol. 141:453-463.
3. Johansen JS, Riis BJ, Hassager C, Moen M, Jacobsen J, Christiansen C. 1988 The effect of gonadotropin-releasing hormone agonist (nafarelin) on bone metabolism. J Clin Endocrinol Metab. 67:701-706.
4. Scialli AR, Jestilla KJ, Simon JA. 1993 Leuprolide Acetate and bone mineral density measured by quantitative digitized radiography. Fertil Steril. 59:674-676.
5. Van Uem JFHM, Hsiu JG, Chilik CF, et al. 1989 Contraceptive potential of RU 486 by ovulation inhibition. I. Pituitary versus ovarian action with the blockade of estrogen induced endometrial proliferation. Contraception. 40:171-184.
6. Kettel ML, Murphy AA, Mortola JF, Liu JH, Ulmann A, Yen SSC. 1991 Endocrine responses to long-term administration of the anti-progesterone RU 486 in patients with pelvic endometriosis. Fertil Steril. 56:402-407.
7. Yen SSC. 1993 Use of antiprogestins in the management of endometriosis and leiomyoma. In: Donaldson MS, Douglinger L, Brown SS, Benet LZ, eds. Clinical applications of mifepristone (RU 486) and other antiprogestins. Washington DC: National Academy Press; 189-209.
8. Murphy AA, Kettel LM, Morales A, Roberts VJ, Yen SSC. 1993 Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab. 76:513-517.
9. Schenken RS, Williams RF, Hodgen GD. 1987 Effect of pregnancy on surgically induced endometriosis in cynomolgus monkeys. Am J Obstet Gynecol. 157:1392-1396.
10. Dizerega GS, Barber DL, Hodgen GD. 1980 Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression. Fertil Steril. 33:649-653.
11. Markee JE. 1940 Menstruation in intraocular endometrial transplants in the rhesus monkey. Contrib Embryol. 28:219.
12. Werlin LB, Hodgen GD. 1983 Gonadotropin-releasing hormone agonist suppresses ovulation, menses, and endometriosis in monkeys: an individualized, intermittent regimen. J Clin Endocrinol Metab. 56:844-848.
13. Hodgen GD, Goodman AL, O'Connor A, Johnson DK. 1977 Menopause in rhesus monkeys: model for study of disorders in the human climacteric. Am J Obstet Gynecol. 127:581-584.
14. Goodman AL, Hodgen GD. 1983 The ovarian triad of the primate menstrual cycle. Recent Prog Horm Res. 39:1-73.
15. Wolf JP, Hsiu JG, Anderson TL, Ulmann A, Baulieu EE, Hodgen GD. 1989 Noncompetitive antiestrogen effect of RU 486 in blocking the estrogen-stimulated luteinizing hormone surge and the proliferative action of estradiol on endometrium in castrate monkeys. Fertil Steril. 52:1055-1060.
16. Stumpf PG, Nakamura RM, Mishell JR. 1981 Changes in physiologically free circulating estradiol and testosterone during exposure to levonorgestrel. J Clin Endocrinol Metab. 52:138-143.
17. Abdalla KA, Shabaan MM, Stanczyk FZ. 1992 Interrelationship of serum levonorgestrel and sex-hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets. Contraception. 45:111-118.
18. Noyes RW, Hertig AT, Rock J. 1950 Dating the endometrial biopsy. Fertil Steril. 1:3.
19. Adashi E. 1994 Long-term gonadotropin-releasing hormone agonist therapy: the evolving issue of steroidal 'add-back' paradigms. Hum Reprod. 9:1380-1397.
20. Friedman AJ, Lobel SM, Rein MS, Barbieri RL. 1990 Efficacy and safety considerations in women with uterine leiomyomas treated with gonadotropin-releasing hormone agonists: the estrogen threshold hypothesis. Am J Obstet Gynecol. 163:1114-1119.
21. Barbieri RL. 1990 Gonadotropin-releasing hormone agonists and estrogen-progestin replacement therapy. Am J Obstet Gynecol. 162:593-595.
22. Matta WH, Shaw RW, Hesp R, et al. 1988 Reversible trabecular bone density loss following induced hypoestrogenism with the GnRH analogue buserelin in premenopausal women. J Clin Endocrinol Metab. 29:45.
23. Barett-Connor E, Wingard DL, Criqui MH. 1989 Postmenopausal estrogen use and heart disease risk factors in the 1980's. JAMA. 261:2095-2100.
24. Neulen J, Williams RF, Hodgen GD. 1990 RU 486 (mifepristone): induction of dose-dependent elevations of estradiol receptor in endometrium from ovariectomized monkeys. J Clin Endocrinol Metab. 71:1074-1075.
25. Danforth DR, Dubois C, Ulmann A, Baulieu EE, Hodgen GD. 1989 Contraceptive potential of RU 486 by ovulation inhibition: preliminary observations on once weekly oral administration. Contraception. 40:195-200.
26. Collins RL, Hodgen GD. 1986 Blockade of the spontaneous midcycle gonadotropin surge in monkeys by RU 486: a progesterone antagonist or agonist? J Clin Endocrinol Metab. 63:1270-1276.
27. Liu JH, Garzo G, Morris S, Strekael C, Ulmann A, Yen SSC. 1987 Disruption of follicular maturation and delay in ovulation after administration of the antiprogestin RU 486. J Clin Endocrinol Metab. 65:1135-1140.
28. Luukkainen T, Heikinheimo O, Haukkamaa M, Lahteenmaki P. 1989 Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. Fertil Steril. 49:961-963.
29. Steingold KA, Cedars M, Lu JKH, Randle D, Judd HL, Meldrum DR. 1987 Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist. Obstet Gynecol 1987:69:403-411.
30. Erlik Y, Meldrum DR, Lagasse LD, Judd HL. 1981 EFfect of megestrol acetate on flushing and bone metabolism in post-menopausal women. Maturatis. 3:167-172.
31. Koering MJ, Healy DL, Hodgen GD. 1986 Morphologic response of endometrium to a progesterone receptor antagonist, RU 486, in monkeys. Fertil Steril 45:280-287.
32. Schaison G. 1989 Antagonist and agonist effects of the antiprogestin RU 486. Ann Endocrinol (Paris). 50:200-207.
33. Danforth DR, Dubois C, Ulmann A, Baulieu EE, Hodgen GD. 1989 Contraceptive potential of RU 486 by ovulation inhibition. III. Preliminary observations on once weekly oral admnistration. Contraception. 40:195-200.
34. American Fertility Society. 1985 Revised American Fertility Society classification of endometriosis. Fertil Steril. 43:351-352.
35. Murphy AA, Kettel LM, Morales AJ, Roberts V, Parmley T, Yen SSC. 1995 Endometrial effects of long-term low-dose administration of RU 486. Fertil Steril. 63:761-766.
36. Christiansen C. 1991 Consensus development conference on osteoporosis. Am J Med. 91:5B-1S.
37. Lindsay R, Hart DM, Forrest C, Baird C. 1980 Prevention of spinal osteoporosis in oophorectomized women. Lancet. 2:1151-1154.
38. Jones KP, Ravnikai VA, Tukhisky D, Schiff I. 1987 Comparison of bone density in amenorrheic women due to athletic weight loss and premature menopause. Obstet Gynecol. 66:5-7.
39. Ericksen EF, Colvard DS, Berg NJ, et al. 1988 Evidence of estrogen receptors in normal human osteoblast-like cells. Science. 241:84-86.
40. Marshew U, Overgaard K, Riis BJ, Christiansen C. 1992 Two new combinations of estrogen and progesterone for prevention of post-menopausal bone loss: long-term effects on bone, calcium, lipid metabolism, climacteric symptoms and bleeding. Obstet Gynecol. 79:202-210.
41. Beall PT, Misra LK, Young RL, Spjut HJ, Evans HJ, LeBlanc A. 1984 Clomiphene protects against osteoporosis in the mature ovariectomized rat. Calcif Tissue Int. 36:123-125.
42. Abassi R, Hodgen GD. 1986 Predicting predisposition to osteoporosis. JAMA. 255:1600-1604.
43. Wright D, Mansell RE, Gaze JC, Compston JE. 1993 Effect of long-term tamoxifen treatment on bone turnover in women with breast cancer. Br Med J 306:429-430.
44. Slayden OD, Brenner RM. 1994 RU 486 action after estrogen priming in the endometrium and oviducts of rehesus monkeys (Macaca mulatta). J Clin Endocrinol Metab. 78:440-448.
45. Chwalisz K, Hegele-Hartung KH, Fritzmeier HM, Beier W, Elger W. 1991 Inhibition of the estradiol-mediated endometrial gland formation by the antigestagen onapristone in rabbits: relationship to uterine estrogen receptors. Endocrinology. 129:312-322.
46. Chwalisz K, Stockemann K, Fritzemeier KH, Gemperiein I, Fuhrmann U, Neff G. 13α-Configurated progesterone antagonists: functional antiestrogenic action in the rat [abstract]. Exp Clin Endocrinol. 101(Suppl 1):60.
47. McDonnell DP, Goldman ME. 1994 RU 486 exerts antiestrognic activities through a novel progesterone receptor A form-mediated mechanism. J Biol Chem. 269:11945-11949.
48. Horwitz KB. 1992 The molecular biology of RU 486. Is there a role for antiprogestins in the treatment of breast cancer? Endocr Rev. 13:146-163.
49. Nieman LK, Chrousos GP, Kellner C, et al. 1985 Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. J Clin Endocrinol Metab. 61:536-540.
50. Laue L, Lotze MT, Chrousos GP, Barnes K, Loriaux DL, Fleisher TA. 1990 Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological and hormonal aspects. J Clin Endocrinol Metab. 71: 1474-1480.